விரிவான நீரிழிவு நோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விரிவான நீரிழிவு நோய் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விரிவான நீரிழிவு நோய் மையம் Today - Breaking & Trending Today

Metformin Treatment Again Linked to Fewer Deaths From COVID-19

Metformin Treatment Again Linked to Fewer Deaths From COVID-19
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United States , Nanne Peters , Los Angeles , University Of Alabama At Birmingham Hospital , Coronavirus Resource Center , Keck School Of Medicine , University Of Southern California , Diabetes Center , University Of Alabama At Birmingham , Coronavirus Resource , African American , Anath Shalev , Comprehensive Diabetes Center , Medscape Medical , Keck School , Southern California , Birmingham Hospital , Mechanisms Includes Anti Inflammatory , ஒன்றுபட்டது மாநிலங்களில் , அன்னே பீட்டர்ஸ் , லாஸ் ஏஞ்சல்ஸ் , பல்கலைக்கழகம் ஆஃப் அலபாமா இல் பர்மிங்காம் மருத்துவமனை , கேக்க் பள்ளி ஆஃப் மருந்து , பல்கலைக்கழகம் ஆஃப் தெற்கு கலிஃபோர்னியா , நீரிழிவு நோய் மையம் , பல்கலைக்கழகம் ஆஃப் அலபாமா இல் பர்மிங்காம் ,

Metformin drug decreases mortality rate in COVID-19 patients with type 2 diabetes

Metformin drug decreases mortality rate in COVID-19 patients with type 2 diabetes
Use of the diabetes drug metformin before a diagnosis of COVID-19 is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure.
Anath Shalev, M.D, Study Lead Author and Director of Comprehensive Diabetes Center, University of Alabama at Birmingham
Since similar results have now been obtained in different populations from around the world including China, France and a UnitedHealthcare analysis this suggests that the observed reduction in mortality risk associated with metformin use in subjects with Type 2 diabetes and COVID-19 might be generalizable, Shalev said. ....

United States , University Of Alabama At Birmingham , Emily Henderson , Diabetes Center , Study Lead Author , Comprehensive Diabetes Center , African American , Chronic Kidney Disease , Heart Failure , Kidney Disease , Type 2 Diabetes , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் அலபாமா இல் பர்மிங்காம் , எமிலி ஹென்டர்சன் , நீரிழிவு நோய் மையம் , படிப்பு வழி நடத்து நூலாசிரியர் , விரிவான நீரிழிவு நோய் மையம் , நீரிழிவு நோய் , நாள்பட்ட கிட்நீ நோய் , இதயம் தோல்வி , கிட்நீ நோய் , வளர்சிதை மாற்றம் , உடல் பருமன் ,

Metformin use reduces risk of death for patients with COVID-19 and diabetes

Credit: UAB
BIRMINGHAM, Ala. - Use of the diabetes drug metformin before a diagnosis of COVID-19 is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure, said Anath Shalev, M.D., director of UAB s Comprehensive Diabetes Center and leader of the study.
Since similar results have now been obtained in different populations from around the world including China, France and a UnitedHealthcare analysis this suggests that the observed reduction in mortality risk associated with metformin use in subjects with Type 2 diabetes and COVID-19 might be generalizable, Shalev said. ....

United States , University Of Alabama At Birmingham , Peng Li , Eugenec Gwaltney , Tiffany Grimes , Andrewb Crouse , Fernando Ovalle , National Institutes Of Health , Diabetes Research , Diabetes Center , Precision Diabetes Program , Hugh Kaul Precision Medicine Institute , Department Of Medicine Division Endocrinology , School Of Nursing , Anath Shalev , African American , Matthew Might , Comprehensive Diabetes Center , Medicine Division , National Institutes , Family Endowed Chair , Juvenile Diabetes , Medicine Health , Infectious Emerging Diseases , Internal Medicine , Pulmonary Respiratory Medicine ,